Clinical Trials
Discoveries About Lumakra Lung Cancer Bolster The KRAS Fight
Amgen is in the lead in a carefully watched race among KRAS inhibitors after winning a lung cancer randomised study. Now, the California drugmaker...
Clinical Trials
EU Officials Make New Work Plan To Speed-Up Clinical Study
The European Commission (EC), Heads of Medicine Agencies (HMA), and European Medicines Agency (EMA) have released the 2022–2026 workplan for the programme Accelerating Clinical...
Drug Research
Prior To FDA Prurigo Nodularis Ruling, Dupixent Wins Again
Dupixent, the immunology favourite developed by Sanofi and Regeneron Pharmaceuticals, is still on the rise. It has received back-to-back approvals this year for the...
IT & Data Management
FDA Experts Favor ALS Drug Amylyx, Shifting Former Stance
A group of Food and Drug Administration advisers has recently come out in favour of a carefully monitored ALS drug, increasing the likelihood that...
Press Releases
Airnov to exhibit range of healthcare packaging solutions at upcoming Connect in Pharma event in Geneva
Airnov Healthcare Packaging, a global leader in controlled atmosphere packaging, will be exhibiting a range of solutions available to customers worldwide at the upcoming...
Press Releases
“Genome Editing of Immune Cells” – New Lonza Virtual Event
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery....
Drug Research
Long-Awaited Daxxify By Revance Will Compete With Botox
Revance Therapeutics may soon run into an identity problem with a product that is so eagerly awaited that some people mistakenly call it by...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read